site stats

Pear therapeutics ticker

WebApr 12, 2024 · With Pear Therapeutics stock trading at $0.72 per share, the total value of Pear Therapeutics stock (market capitalization) is $100.19M. Pear Therapeutics stock was originally listed at a price of $10.35 in Feb 2, 2024. WebJan 4, 2024 · Current Report Filing (8-k) • Edgar (US Regulatory) • 04/10/2024 08:37:28 PM Current Report Filing (8-k) • Edgar (US Regulatory) • 04/07/2024 03:33:16 PM Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process • Business Wire • 04/07/2024 03:30:00 PM ; Sight Sciences Appoints Ali Bauerlein as Chief …

Pear Therapeutics - Crunchbase Company Profile & Funding

WebWebull offers PEAR THERAPEUTICS INC PEAR historical stock prices, in-depth market analysis,NASDAQ:PEAR real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. WebIts commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use … property documents tallahassee fl https://remingtonschulz.com

PEAR - Stock Quotes for PEAR THERAPEUTICS INC,NASDAQ:PEAR …

WebDec 3, 2024 · Publicly traded company called Pear Therapeutics, Inc. to begin trading on Nasdaq under ticker symbol “PEAR” starting December 6, 2024 Total expected gross proceeds from transaction totaling approximately $175 million WebGet the latest Pear Therapeutics Inc (PEAR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … WebMar 17, 2024 · Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs).Pear aims to redefine care through the widespread use of clinically validated … property documents required for home loan sbi

Pear Therapeutics - PEAR - Stock Price Today - Zacks

Category:PEAR THERAPEUTICS, INC. : Notice of Delisting or Failure to …

Tags:Pear therapeutics ticker

Pear therapeutics ticker

PEAR: Pear Therapeutics Inc - Stock Price, Quote and News - CNBC

WebNov 14, 2024 · Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today reported results for its third quarter ended September 30, 2024. “Pear is making strong and steady progress toward our mission of making PDTs mainstream medicine,” said … WebApr 15, 2024 · 米Pear Therapeutics社は2024年3月21日、睡眠・覚醒障害のデジタル治療開発でソフトバンクと提携したと発表した。 Pear社が日本語版のデジタル治療用アプリを開発し、ソフトバンクは日本市場におけるアプリの需要や有用性などを調査する。

Pear therapeutics ticker

Did you know?

WebApr 6, 2024 · View Pear Therapeutics, Inc PEAR investment & stock information. Get the latest Pear Therapeutics, Inc PEAR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. WebPear discovers, develops, and delivers clinically validated software to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost …

WebPrice. Webull offers kinds of Pear Therapeutics Inc stock information, including NASDAQ:PEAR real-time market quotes, financial reports, professional analyst ratings, in … WebNov 15, 2024 · BOSTON – November 15, 2024 – Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today provides an update on significant progress in its commercialization, pipeline, and platform strategy prior to the expected closing of its …

WebApr 6, 2024 · Pear Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. Sector Health Care Industry Health Care Technology Employees 260 Founded 2013 Address 200 State... WebPEAR Complete Pear Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

WebPear Therapeutics (PEAR) Price To Cash Flow - Zacks.com Pear Therapeutics (PEAR) (Delayed Data from NSDQ) $0.07 USD -0.05 (-39.24%) Updated Apr 14, 2024 03:59 PM ET After-Market:...

WebApr 13, 2024 · Pear Therapeutics said it would grow from $4 million in 2024 to a whopping $125 million by the end of 2024. It didn’t come close. property documents verification in bangaloreWebPEAR THERAPEUTICS AND THIMBLE POINT ANNOUNCE CLOSING OF BUSINESS COMBINATION TO CREATE PUBLICLY TRADED PRESCRIPTION DIGITAL THERAPEUTICS … lads of the fairWebMar 28, 2024 · Pear Therapeutics, Inc. is a commercial-stage healthcare company. The Company is engaged in developing a new class of software-based medicines that is referred to as prescription digital therapeutics (PDTs), which use software to treat diseases. Its products include reset, reSET-O and Somryst. lads in y fronts